Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flagellin is the main structural protein of the flagellar filament in Salmonella Typhi, responsible for bacterial motility and key interactions with the host. Each filament is made of thousands of flagellin subunits, arranged to form a long whip-like appendage[1]. In Salmonella Typhi, the flagellin gene is monophasic (encodes only FliC), unlike biphasic strains such as S. Typhimurium, which encode both FliC and FljB. Flagellin mediates motility, but also facilitates host cell invasion and influences the expression of other virulence factors, particularly the Salmonella pathogenicity island 1 (SPI-1) secretion system[3]. Besides its structural function, flagellin is recognized by host immune receptors (TLR5), triggering a strong inflammatory response[3]. Flagellin is among the best-known bacterial antigens (“H antigen”) and is exploited as a target for immunological detection, vaccine development, and as an adjuvant. In S. Typhi, flagellin is crucial for virulence, colonization, and modulation of immune responses, though it does not appear to be directly targeted by approved antimicrobials; rather, it is a tool and target for immunoprophylaxis and diagnostics[1][3]. Safety concerns with flagellin-based therapeutics stem from its inherent ability to induce robust inflammation[3].
Immune activation: flagellin is recognized by Toll-like receptor 5 (TLR5) on host cells, leading to pro-inflammatory signaling; Vaccine/adjuvant: purified flagellin or flagellin fragments can be used to boost immune responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Typhi flagellin (FliC (for the phase 1 flagellin in S. Typhi; FljB refers to phase 2 flagellin in other Salmonella serovars)).